LifeStance to announce Q2FY26 earnings on August 6, 2026

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights

LifeStance Health Group, Inc. announced it will release its Q2FY26 earnings on August 6, 2026, before market open. A conference call is scheduled for 8:30 a.m. ET to discuss the results. The webcast and replay will be available on the company's Investor Relations website.

powered bylight_fuzz_icon
45779131

*this image is generated using AI for illustrative purposes only.

LifeStance Health Group, Inc. will issue its second quarter 2026 earnings release before the market opens on August 6, 2026. The company, one of the nation’s largest providers of outpatient mental healthcare, will host a live earnings conference call to discuss the results at 8:30 a.m. Eastern Time on the same day.

Conference Call Details

To participate in the call, domestic participants can dial 1-800-715-9871, while international participants can dial 1-646-307-1963. The conference ID required for participation is 6776851. Alternatively, participants can ask to be joined into the LifeStance call.

Webcast and Replay

A real-time audio webcast of the conference call will be accessible via the Events and Presentations section of the LifeStance Investor Relations website. Related materials will be posted on the website prior to the call. A replay of the webcast will be available after the conclusion of the conference call on the same platform.

About LifeStance Health Group

Founded in 2017, LifeStance provides virtual and in-person outpatient mental healthcare for children, adolescents, and adults. The company operates across 33 states with more than 550 centers, employing over 8,300 psychiatrists, advanced practice nurses, psychologists, and therapists.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

What market trends in outpatient mental healthcare could influence LifeStance's Q2 2026 performance?

How might LifeStance's expansion into new states impact its earnings in the upcoming quarters?

What role will telehealth play in LifeStance's growth strategy moving forward?

like20
dislike

Keybanc raises LifeStance Health Gr price target to $13

scanx
Reviewed by
Radhika SScanX News Team
Key Highlights

Keybanc analyst Steve Dechert maintained an Overweight rating on LifeStance Health Gr (NASDAQ: LFST) and raised the price target to $13 from $11, indicating a positive outlook.

powered bylight_fuzz_icon
45493281

*this image is generated using AI for illustrative purposes only.

Keybanc analyst Steve Dechert has maintained an Overweight rating for LifeStance Health Gr (NASDAQ: LFST) while raising the price target to $13 from the previous $11. This revision signals increased confidence in the company's near-term stock performance.

The decision to upgrade the price target comes as LifeStance Health Gr continues to navigate the behavioral health market. The Overweight rating suggests that the stock is expected to outperform the broader market or its sector peers in the coming period.

Investors following LifeStance Health Gr will note that the new price target of $13 represents a specific upside from the prior target of $11. The rating and target adjustments are based on the analyst's assessment of the company's operational and financial trajectory.

Analyst Rating and Price Target

Metric Value
Rating Overweight
Previous Price Target $11
New Price Target $13

The revised target provides a clear benchmark for market participants evaluating the stock's potential. LifeStance Health Gr operates within the healthcare sector, specifically focusing on mental health services.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

What specific operational milestones does LifeStance need to achieve to justify the new $13 price target?

How might current macroeconomic conditions impact patient demand for behavioral health services in the near term?

Could this rating revision trigger a broader re-rating of the behavioral health sector among institutional investors?

like15
dislike